Today's pre-market stock movers: KSS, TGT, GTLB, SJM and more
+4.6% (reports phase 2 clinical trial results demonstrating upstream classical complement inhibition associated with clinical benefit in Huntington's disease)
+3.7% (FDA will hold meeting regarding NVAX COVID-19 vaccine for individuals 18 and older today at 8:30 ET)
+2.7% (Tang Capital discloses 5.2% stake; submits emergency use authorization application to U.S. FDA for Sabizabulin)
+2.7% (KSS Board of Directors enters into three-week exclusive negotiations with Franchise Group (FR.G)
+1.4% (collaboration with Novo Nordisk (NVO) to create novel expression hosts for pharmaceutical products)
Disclaimer: Moomoo Technologies Inc. is providing this content for information and educational use only.